COAPT Risk Score

Curated by Signal

Provider of a risk assessment tool for mitral regurgitation

Overview

Provider of a risk assessment tool for mitral regurgitation. It is a clinical decision support tool that predicts the risk of death or heart failure hospitalization in patients with severe functional mitral regurgitation.

Key facts

Founded: 2023
Headquarters: New York, United States
Stage: Sign up to view
Industry: Health Technology

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

HealthBlocks
Provider of solutions for connectivity, interfacing, and integration for healthcare professionals
Health TechnologyDuncanville, United States
Patient Sleep Supplies
Online pharmacy offering sleep-related products and medications
Health TechnologyThousand Oaks, United States
B-Line Medical
Simulation and video learning based solutions for healthcare providers and medical institutions
Health TechnologyWashington, DC, United States

About COAPT Risk Score

What does COAPT Risk Score do?

Provider of a risk assessment tool for mitral regurgitation.

Where is COAPT Risk Score headquartered?

COAPT Risk Score is headquartered in New York, United States.

When was COAPT Risk Score founded?

COAPT Risk Score was founded in 2023.

Which sector is COAPT Risk Score in?

COAPT Risk Score operates in Health Technology.

Who are COAPT Risk Score's competitors?

Companies similar to COAPT Risk Score include HealthBlocks, Patient Sleep Supplies, and B-Line Medical.